Integrating PET/CT and correlative biomarkers for prospective evaluation of extramedullary disease in relapsed/refractory B-ALL: implications for CAR T-cell therapy.
Journal: Journal for immunotherapy of cancer
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Solter ML, Wang YJ, Li G, et al. (2026). "Integrating PET/CT and correlative biomarkers for prospective evaluation of extramedullary disease in relapsed/refractory B-ALL: implications for CAR T-cell therapy.". Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2026-016031